Table 3 Pathologic staging and subtypes of included articles after radiotherapy
Study | Pathologic T stage (n; %) | Pathologic N stage (n; %) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ypT0 | ypT1 | ypT2 | ypT3 | ypT4 | ypN0 | ypN1–2 | ||||||||
RS | LE | RS | LE | RS | LE | RS | LE | RS | LE | RS | LE | RS | LE | |
Ayloor [16] | 6 | – | – | – | 3 | – | 1 | – | – | – | 6 | – | 5 | – |
Dalton [17] | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Habr [11] | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Lai [18] | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Lee [19] | 13 | 6 | 2 | 6 | 9 | 4 | 4 | 0 | 0 | 0 | 24 | – | 4 | – |
Li [20] | – | – | – | – | – | – | – | – | – | – | – | |||
Mass [21] | – | – | – | – | – | – | – | – | – | – | – | |||
Renehan [22] | – | – | – | – | – | – | – | – | – | – | – | |||
Smith [23] | – | – | – | – | – | – | – | – | – | – | – | |||
Yeom [24] | 46 | 12 | 47 | 11 | – | – | 36 | 2 | – | – | 108 | – | 21 | – |
Wang [25] | – | – | – | – | – | – | – | – | – | – | – | |||
Total | 65 (38.9) | 18 (43.9) | 49 (29.3) | 17 (41.4) | 12 (7.1) | 4 (9.7) | 41 (24.7) | 2 (5) | 0 | 0 | 138 (82.1) | 30 (17.9) | – | |
Pathologic subtypes | ||||||||||||||
Well differentiated | Moderate differentiated | Poorly differentiated | Unknown | |||||||||||
WS | RS | WS | RS | WS | RS | WS | RS | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
5 | 15 | 86 | 104 | 2 | 14 | 36 | 95 | |||||||
– | – | – | – | – | – | – | – | |||||||
– | – | – | – | – | – | – | – | |||||||
2 | 29 | 45 | 126 | 2 | 0 | 10 | 24 | |||||||